Skip to content

Omeros

US · OMER #3062 by market cap Listed 1970
13.21 -0.80 -5.71%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Omeros

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Founded
1994
CEO
Dr. Gregory A. Demopulos,M.D.
Employees
175
Headquarters
Seattle, Washington, United States of America
Fiscal year end
12-31
Website
omeros.com

Company profile

Exchange
US
Symbol
OMER
Market-cap rank
#3062
Listing date
1970-01-01
Market cap
983.66M
Float cap
942.68M
Shares out
74.46M
Float shares
71.36M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 20:02:33 · For reference only, not investment advice and not tailored to your situation.

Omeros discussion 0 comments

Add a comment